- Filed
- Mar 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Mar 3, 2026 | 44.49M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 44.98M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 44.83M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 44.4M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 45.07M sh |
| Stock Repurchased | Q3 2026 · Jan 31, 2026 | $0 |
| Stock Repurchased | Q3 2026 · Jan 31, 2025 | $25.47M |
| Dividends Paid | Q3 2026 · Jan 31, 2026 | $17.44M |
| Dividends Paid | Q3 2026 · Jan 31, 2025 | $17.38M |
| Capex | Q3 2026 · Jan 31, 2026 | $18.91M |
| Capex | Q3 2026 · Jan 31, 2025 | $14.31M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2026 | $39.61M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2025 | −$48.05M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2026 | $18.42M |
| Cash And Equivalents | Q3 2026 · Apr 30, 2025 | $25.23M |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | $363.42M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | $363.2M |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | $372.45M |
| Stockholders Equity restated | Q3 2026 · Jan 31, 2025 | $366.93M |
| Stockholders Equity restated | Q3 2026 · Oct 31, 2024 | $371.48M |
| Stockholders Equity restated | Q3 2026 · Apr 30, 2024 | $399.91M |
| Current Liabilities | Q3 2026 · Jan 31, 2026 | $58.14M |
| Current Liabilities | Q3 2026 · Apr 30, 2025 | $66.64M |
| Total Liabilities | Q3 2026 · Jan 31, 2026 | $174.59M |
| Total Liabilities | Q3 2026 · Apr 30, 2025 | $187.16M |
| Current Assets | Q3 2026 · Jan 31, 2026 | $261.53M |
| Current Assets | Q3 2026 · Apr 30, 2025 | $277.27M |
| Total Assets | Q3 2026 · Jan 31, 2026 | $538M |
| Total Assets | Q3 2026 · Apr 30, 2025 | $559.61M |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | $0.08 |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | $0.05 |
| Eps Diluted restated | Q3 2026 · Jan 31, 2025 | $0.05 |
| Eps Diluted restated | Q3 2026 · Jan 31, 2025 | $0.11 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | $0.08 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | $0.05 |
| Eps Basic restated | Q3 2026 · Jan 31, 2025 | $0.05 |
| Eps Basic restated | Q3 2026 · Jan 31, 2025 | $0.11 |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $15.48M |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $42.26M |
| Sga Expense restated | Q3 2026 · Jan 31, 2025 | $12.38M |
| Sga Expense restated | Q3 2026 · Jan 31, 2025 | $40.96M |
| Rd Expense | Q3 2026 · Jan 31, 2026 | $2.41M |
| Rd Expense | Q3 2026 · Jan 31, 2026 | $7.85M |
| Rd Expense | Q3 2026 · Jan 31, 2025 | $2.87M |
| Rd Expense | Q3 2026 · Jan 31, 2025 | $7.61M |
| Net Income | Q3 2026 · Jan 31, 2026 | $3.75M |
| Net Income | Q3 2026 · Jan 31, 2026 | $2.26M |
| Net Income restated | Q3 2026 · Jan 31, 2025 | $2.1M |
| Net Income restated | Q3 2026 · Jan 31, 2025 | $4.79M |
| Operating Income | Q3 2026 · Jan 31, 2026 | $6.71M |
| Operating Income | Q3 2026 · Jan 31, 2026 | $7.87M |
| Operating Income restated | Q3 2026 · Jan 31, 2025 | $4.75M |
| Operating Income restated | Q3 2026 · Jan 31, 2025 | $10.76M |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $35.59M |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $88.01M |
| Gross Profit | Q3 2026 · Jan 31, 2025 | $27.95M |
| Gross Profit | Q3 2026 · Jan 31, 2025 | $86.64M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $100.12M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $257.44M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2025 | $87.94M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2025 | $247.26M |
| Revenue | Q3 2026 · Jan 31, 2026 | $135.71M |
| Revenue | Q3 2026 · Jan 31, 2026 | $345.46M |
| Revenue | Q3 2026 · Jan 31, 2025 | $115.89M |
| Revenue | Q3 2026 · Jan 31, 2025 | $333.9M |